Center of Excellence for Individualization of Therapy for Breast Cancer

Abstract

Optical systemic treatment after breast cancer is the most crucial factor in reducing mortality in women with breast cancer. Adjuvant chemotherapy and hormonal treatment both reduce the risk of death in breast cancer patients. However, while estrogen receptors status predicts for response to hormone treatments, there are no clinically useful predictive markers for chemotherapy responses. All eligible women are therefore treated in the same manner. Even denoval drug resistance will result in treatment failures in many breast cancer patients.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Apr 01, 2006
Accession Number
ADA458394

Entities

People

  • Ann Thor
  • Brian Leyland-jones
  • George W. Sledge
  • Jenny Chang
  • Kathy D. Miller
  • Robert J. Hickey

Organizations

  • Indiana University

Tags

DTIC Thesaurus Topics

  • Abstracts
  • Biomedical Research
  • Breast Cancer
  • Chemotherapy
  • Department Of Defense
  • Drug Resistance
  • Drug Therapy
  • Electronic Mail
  • Information Operations
  • Neoplasms
  • Therapy
  • Universities

Fields of Study

  • Medicine

Readers

  • Breast cancer cell signaling and growth regulation.
  • Gulf War Illness and Chronic Multisymptom Illness in Veterans.
  • Women's Health and Cancer Risk Research: African American Women and Pregnancy Outcomes.